Literature DB >> 16417771

Study of traditional chinese medicine-which is after all the right way?

Ke-ji Chen, Li-zhi Li.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16417771     DOI： 10.1007/bf02835782

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


× No keyword cloud information.
  7 in total

1.  Clinical service of Chinese medicine.

Authors:  Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2008-10-14       Impact factor: 1.978

Review 2.  Wendan decoction (温胆汤) for treatment of schizophrenia: a systematic review of randomized controlled trials.

Authors:  Yi-wen Che; Ke-yu Yao; Yu-peng Xi; Zi-jie Chen; Yong-le Li; Ning Yu; Shuang-qing Zhai
Journal:  Chin J Integr Med       Date:  2015-04-06       Impact factor: 1.978

3.  Banxia baizhu tianma decoction for essential hypertension: a systematic review of randomized controlled trials.

Authors:  Xingjiang Xiong; Xiaochen Yang; Wei Liu; Bo Feng; Jizheng Ma; Xinliang Du; Pengqian Wang; Fuyong Chu; Jun Li; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-20       Impact factor: 2.629

Review 4.  Chinese herbal medicine for acute mountain sickness: a systematic review of randomized controlled trials.

Authors:  Jie Wang; Xingjiang Xiong; Yanwei Xing; Zhen Liu; Wenrui Jiang; Junyi Huang; Bo Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-22       Impact factor: 2.629

Review 5.  Aspirin resistance and promoting blood circulation and removing blood stasis: current situation and prospectives.

Authors:  Jie Wang; Xingjiang Xiong; Bo Feng
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-18       Impact factor: 2.629

6.  Evidence-based chinese medicine for hypertension.

Authors:  Jie Wang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-03       Impact factor: 2.629

7.  Trends in the treatment of hypertension from the perspective of traditional chinese medicine.

Authors:  Xingjiang Xiong; Xiaochen Yang; Wei Liu; Fuyong Chu; Pengqian Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-26       Impact factor: 2.629
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.